Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Flow Cytometry
1.2.3 Polymerase Chain Reaction
1.2.4 Next-generation Sequencing
1.2.5 Liquid Biopsies
1.3 Market by Application
1.3.1 Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Specialty Clinics
1.3.3 Hospitals
1.3.4 Research Institutions
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Minimal Residual Disease (MRD) Testing Market Perspective (2018-2033)
2.2 Global Minimal Residual Disease (MRD) Testing Growth Trends by Region
2.2.1 Minimal Residual Disease (MRD) Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Minimal Residual Disease (MRD) Testing Historic Market Size by Region (2018-2023)
2.2.3 Minimal Residual Disease (MRD) Testing Forecasted Market Size by Region (2024-2033)
2.3 Minimal Residual Disease (MRD) Testing Market Dynamics
2.3.1 Minimal Residual Disease (MRD) Testing Industry Trends
2.3.2 Minimal Residual Disease (MRD) Testing Market Drivers
2.3.3 Minimal Residual Disease (MRD) Testing Market Challenges
2.3.4 Minimal Residual Disease (MRD) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Minimal Residual Disease (MRD) Testing by Players
3.1.1 Global Minimal Residual Disease (MRD) Testing Revenue by Players (2018-2023)
3.1.2 Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Players (2018-2023)
3.2 Global Minimal Residual Disease (MRD) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Minimal Residual Disease (MRD) Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Minimal Residual Disease (MRD) Testing Market Concentration Ratio
3.4.1 Global Minimal Residual Disease (MRD) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Minimal Residual Disease (MRD) Testing Revenue in 2022
3.5 Global Key Players of Minimal Residual Disease (MRD) Testing Head office and Area Served
3.6 Global Key Players of Minimal Residual Disease (MRD) Testing, Product and Application
3.7 Global Key Players of Minimal Residual Disease (MRD) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Minimal Residual Disease (MRD) Testing Breakdown Data by Type
4.1 Global Minimal Residual Disease (MRD) Testing Historic Market Size by Type (2018-2023)
4.2 Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Type (2024-2033)
5 Minimal Residual Disease (MRD) Testing Breakdown Data by Application
5.1 Global Minimal Residual Disease (MRD) Testing Historic Market Size by Application (2018-2023)
5.2 Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
6.2 North America Minimal Residual Disease (MRD) Testing Market Size by Type
6.2.1 North America Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
6.2.2 North America Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033)
6.2.3 North America Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
6.3 North America Minimal Residual Disease (MRD) Testing Market Size by Application
6.3.1 North America Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
6.3.2 North America Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033)
6.3.3 North America Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
6.4 North America Minimal Residual Disease (MRD) Testing Market Size by Country
6.4.1 North America Minimal Residual Disease (MRD) Testing Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023)
6.4.3 North America Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
7.2 Europe Minimal Residual Disease (MRD) Testing Market Size by Type
7.2.1 Europe Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
7.2.2 Europe Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033)
7.2.3 Europe Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
7.3 Europe Minimal Residual Disease (MRD) Testing Market Size by Application
7.3.1 Europe Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
7.3.2 Europe Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033)
7.3.3 Europe Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
7.4 Europe Minimal Residual Disease (MRD) Testing Market Size by Country
7.4.1 Europe Minimal Residual Disease (MRD) Testing Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023)
7.4.3 Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
8.2 China Minimal Residual Disease (MRD) Testing Market Size by Type
8.2.1 China Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
8.2.2 China Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033)
8.2.3 China Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
8.3 China Minimal Residual Disease (MRD) Testing Market Size by Application
8.3.1 China Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
8.3.2 China Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033)
8.3.3 China Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
9.2 Asia Minimal Residual Disease (MRD) Testing Market Size by Type
9.2.1 Asia Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
9.2.2 Asia Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033)
9.2.3 Asia Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
9.3 Asia Minimal Residual Disease (MRD) Testing Market Size by Application
9.3.1 Asia Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
9.3.2 Asia Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033)
9.3.3 Asia Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
9.4 Asia Minimal Residual Disease (MRD) Testing Market Size by Region
9.4.1 Asia Minimal Residual Disease (MRD) Testing Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2023)
9.4.3 Asia Minimal Residual Disease (MRD) Testing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sysmex Corporation
11.1.1 Sysmex Corporation Company Details
11.1.2 Sysmex Corporation Business Overview
11.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Introduction
11.1.4 Sysmex Corporation Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.1.5 Sysmex Corporation Recent Developments
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera Minimal Residual Disease (MRD) Testing Introduction
11.2.4 Natera Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.2.5 Natera Recent Developments
11.3 Asuragen
11.3.1 Asuragen Company Details
11.3.2 Asuragen Business Overview
11.3.3 Asuragen Minimal Residual Disease (MRD) Testing Introduction
11.3.4 Asuragen Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.3.5 Asuragen Recent Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Details
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Introduction
11.4.4 Quest Diagnostics Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.4.5 Quest Diagnostics Recent Developments
11.5 Mission Bio
11.5.1 Mission Bio Company Details
11.5.2 Mission Bio Business Overview
11.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Introduction
11.5.4 Mission Bio Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.5.5 Mission Bio Recent Developments
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Minimal Residual Disease (MRD) Testing Introduction
11.6.4 LabCorp Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.6.5 LabCorp Recent Developments
11.7 Guardant Health
11.7.1 Guardant Health Company Details
11.7.2 Guardant Health Business Overview
11.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Introduction
11.7.4 Guardant Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.7.5 Guardant Health Recent Developments
11.8 NeoGenomics Laboratories
11.8.1 NeoGenomics Laboratories Company Details
11.8.2 NeoGenomics Laboratories Business Overview
11.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Introduction
11.8.4 NeoGenomics Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.8.5 NeoGenomics Laboratories Recent Developments
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Details
11.9.2 ARUP Laboratories Business Overview
11.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Introduction
11.9.4 ARUP Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.9.5 ARUP Laboratories Recent Developments
11.10 NeoGenomics , Inc
11.10.1 NeoGenomics , Inc Company Details
11.10.2 NeoGenomics , Inc Business Overview
11.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Introduction
11.10.4 NeoGenomics , Inc Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.10.5 NeoGenomics , Inc Recent Developments
11.11 Opko Health
11.11.1 Opko Health Company Details
11.11.2 Opko Health Business Overview
11.11.3 Opko Health Minimal Residual Disease (MRD) Testing Introduction
11.11.4 Opko Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.11.5 Opko Health Recent Developments
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Details
11.12.2 Bio-Rad Laboratories Business Overview
11.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Introduction
11.12.4 Bio-Rad Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.12.5 Bio-Rad Laboratories Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Flow Cytometry
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Next-generation Sequencing
Table 5. Key Players of Liquid Biopsies
Table 6. Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Minimal Residual Disease (MRD) Testing Market Share by Region (2018-2023)
Table 10. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Minimal Residual Disease (MRD) Testing Market Share by Region (2024-2033)
Table 12. Minimal Residual Disease (MRD) Testing Market Trends
Table 13. Minimal Residual Disease (MRD) Testing Market Drivers
Table 14. Minimal Residual Disease (MRD) Testing Market Challenges
Table 15. Minimal Residual Disease (MRD) Testing Market Restraints
Table 16. Global Minimal Residual Disease (MRD) Testing Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Minimal Residual Disease (MRD) Testing Revenue Share by Players (2018-2023)
Table 18. Global Top Minimal Residual Disease (MRD) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Testing as of 2022)
Table 19. Global Minimal Residual Disease (MRD) Testing Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Minimal Residual Disease (MRD) Testing Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Minimal Residual Disease (MRD) Testing, Headquarters and Area Served
Table 22. Global Key Players of Minimal Residual Disease (MRD) Testing, Product and Application
Table 23. Global Key Players of Minimal Residual Disease (MRD) Testing, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2018-2023)
Table 27. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2024-2033)
Table 29. Global Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Minimal Residual Disease (MRD) Testing Revenue Share by Application (2018-2023)
Table 31. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Minimal Residual Disease (MRD) Testing Revenue Share by Application (2024-2033)
Table 33. North America Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Minimal Residual Disease (MRD) Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Minimal Residual Disease (MRD) Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Minimal Residual Disease (MRD) Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Minimal Residual Disease (MRD) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 65. Sysmex Corporation Company Details
Table 66. Sysmex Corporation Business Overview
Table 67. Sysmex Corporation Minimal Residual Disease (MRD) Testing Product
Table 68. Sysmex Corporation Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 69. Sysmex Corporation Recent Developments
Table 70. Natera Company Details
Table 71. Natera Business Overview
Table 72. Natera Minimal Residual Disease (MRD) Testing Product
Table 73. Natera Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 74. Natera Recent Developments
Table 75. Asuragen Company Details
Table 76. Asuragen Business Overview
Table 77. Asuragen Minimal Residual Disease (MRD) Testing Product
Table 78. Asuragen Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 79. Asuragen Recent Developments
Table 80. Quest Diagnostics Company Details
Table 81. Quest Diagnostics Business Overview
Table 82. Quest Diagnostics Minimal Residual Disease (MRD) Testing Product
Table 83. Quest Diagnostics Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 84. Quest Diagnostics Recent Developments
Table 85. Mission Bio Company Details
Table 86. Mission Bio Business Overview
Table 87. Mission Bio Minimal Residual Disease (MRD) Testing Product
Table 88. Mission Bio Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 89. Mission Bio Recent Developments
Table 90. LabCorp Company Details
Table 91. LabCorp Business Overview
Table 92. LabCorp Minimal Residual Disease (MRD) Testing Product
Table 93. LabCorp Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 94. LabCorp Recent Developments
Table 95. Guardant Health Company Details
Table 96. Guardant Health Business Overview
Table 97. Guardant Health Minimal Residual Disease (MRD) Testing Product
Table 98. Guardant Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 99. Guardant Health Recent Developments
Table 100. NeoGenomics Laboratories Company Details
Table 101. NeoGenomics Laboratories Business Overview
Table 102. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product
Table 103. NeoGenomics Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 104. NeoGenomics Laboratories Recent Developments
Table 105. ARUP Laboratories Company Details
Table 106. ARUP Laboratories Business Overview
Table 107. ARUP Laboratories Minimal Residual Disease (MRD) Testing Product
Table 108. ARUP Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 109. ARUP Laboratories Recent Developments
Table 110. NeoGenomics , Inc Company Details
Table 111. NeoGenomics , Inc Business Overview
Table 112. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product
Table 113. NeoGenomics , Inc Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 114. NeoGenomics , Inc Recent Developments
Table 115. Opko Health Company Details
Table 116. Opko Health Business Overview
Table 117. Opko Health Minimal Residual Disease (MRD) Testing Product
Table 118. Opko Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 119. Opko Health Recent Developments
Table 120. Bio-Rad Laboratories Company Details
Table 121. Bio-Rad Laboratories Business Overview
Table 122. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product
Table 123. Bio-Rad Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 124. Bio-Rad Laboratories Recent Developments
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Minimal Residual Disease (MRD) Testing Market Share by Type: 2022 VS 2033
Figure 3. Flow Cytometry Features
Figure 4. Polymerase Chain Reaction Features
Figure 5. Next-generation Sequencing Features
Figure 6. Liquid Biopsies Features
Figure 7. Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Minimal Residual Disease (MRD) Testing Market Share by Application: 2022 VS 2033
Figure 9. Specialty Clinics Case Studies
Figure 10. Hospitals Case Studies
Figure 11. Research Institutions Case Studies
Figure 12. Minimal Residual Disease (MRD) Testing Report Years Considered
Figure 13. Global Minimal Residual Disease (MRD) Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Minimal Residual Disease (MRD) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Minimal Residual Disease (MRD) Testing Market Share by Region: 2022 VS 2033
Figure 16. Global Minimal Residual Disease (MRD) Testing Market Share by Players in 2022
Figure 17. Global Top Minimal Residual Disease (MRD) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Testing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Minimal Residual Disease (MRD) Testing Revenue in 2022
Figure 19. North America Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 21. North America Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 22. North America Minimal Residual Disease (MRD) Testing Market Share by Country (2018-2033)
Figure 23. United States Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Minimal Residual Disease (MRD) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 27. Europe Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 28. Europe Minimal Residual Disease (MRD) Testing Market Share by Country (2018-2033)
Figure 29. Germany Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Minimal Residual Disease (MRD) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 37. China Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 38. Asia Minimal Residual Disease (MRD) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 40. Asia Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 41. Asia Minimal Residual Disease (MRD) Testing Market Share by Region (2018-2033)
Figure 42. Japan Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Minimal Residual Disease (MRD) Testing Market Share by Country (2018-2033)
Figure 52. Brazil Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Sysmex Corporation Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 59. Natera Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 60. Asuragen Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 61. Quest Diagnostics Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 62. Mission Bio Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 63. LabCorp Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 64. Guardant Health Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 65. NeoGenomics Laboratories Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 66. ARUP Laboratories Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 67. NeoGenomics , Inc Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 68. Opko Health Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 69. Bio-Rad Laboratories Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed